In Brief: Gull Laboratories
This article was originally published in The Gray Sheet
Executive SummaryGull Laboratories: Milton Adair, president and CEO of the Salt Lake City-based infectious disease and autoimmune diagnostic test kit manufacturer, steps down from his post due to "differences in business strategies" with the firm's board. Ernest Sumsion, Gull's vice president of technical marketing, will serve as interim president while the company conducts a search for a replacement...
You may also be interested in...
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.
Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales of around €120m.